Glenmark Pharmaceuticals Inc., based in New Jersey, has voluntarily recalled thousands of units of bisoprolol fumarate and ...
Post hoc trial findings support aprocitentan’s potential cardiovascular and kidney-protective effects in patients with chronic kidney disease (CKD) with resistant hypertension.
960 The Ref on MSN
Recall alert: Blood pressure medication recalled; may be contaminated with wrong drug
The Food and Drug Administration has recalled a popular treatment for high blood pressure. The agency said that bottles of bisoprolol fumarate and hydrochlorothiazide tablets, under the brand name ...
The Food and Drug Administration says 11,136 bottles of a blood pressure medication sold under the brand name Ziac have been ...
A specific graft-versus-host disease prophylaxis regimen may expand allogeneic hematopoietic stem cell transplant access to ...
New Jersey-based Glenmark Pharmaceuticals Inc. issued a recall Dec. 1 for its bisoprolol fumarate and hydrocholorothiazide ...
The Food and Drug Administration (FDA) classified the recall with a Class lll risk level, suggesting that exposure to the ...
The recall involves 11,136 bottles of Bisoprolol Fumarate and Hydrochlorothiazide Tablets, USP, 2.5 mg/6.25 mg — under the ...
Glenmark Pharmaceuticals Inc. in Elmwood Park, N.J., is recalling the pills, which are in 2.5 mg and 6.25 mg doses.
The FDA has recalled thousands of Ziac blood pressure tablets after traces of a cholesterol drug were found during testing, ...
Glenmark Pharmaceuticals Inc. has recalled more than 11,100 bottles of bisoprolol fumarate and hydrochlorothiazide tablets ...
Glenmark Pharmaceuticals that has headquarters in North Jersey has recalled a blood pressure medication because of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback